Asepha, a Toronto, Canada-based startup leveraging agentic AI to streamline pharmacy operations, has raised $4 million in seed funding.
Investors
The round was led by Glasswing Ventures and Core Innovation Capital, with participation from Panache, RedBud, MGV, Ripple Ventures, and Front Row Ventures.
Glasswing Ventures is a Boston-based venture capital firm founded in 2016 that specializes in early-stage investments in AI-native and frontier-technology startups in enterprise software and security.
Headquartered in Los Angeles, with an additional presence in San Francisco, Core Innovation Capital is a mission-driven venture capital firm investing in early-stage financial technology companies aimed at improving the lives of everyday Americans.
Asepha Use of Funds
The company will use the funding to grow its engineering and go-to-market teams, expand partnerships, and establish a new office in New York City.
About Asepha
Founded in 2023 by Eunice Wu and Can Uncu, Asepha is building AI-powered pharmacy solutions designed to streamline pharmacy operations. The company develops AI agents to automate and optimize pharmacy workflows. Its tools include OCR prescription entry, call automation, and browser navigation agents, helping pharmacies reduce manual workload and improve patient access. Headquartered in Toronto, Canada, Asepha leverages deep healthcare and technical expertise to reduce administrative burden and enhance access to care.
Funding Details
Company: Asepha
Raised: $4.0M
Round: Seed
Funding Date: July 2025
Lead Investors: Glasswing Ventures, Core Innovation Capital
Additional Investors: Panache, RedBud, MGV, Ripple Ventures, Front Row Ventures
Company Website: https://www.asepha.ai/
Software Category: Pharmacy Automation / AI Agents / Healthcare Technology
Source: Sarah Becker